Barlesi F - Search Results

1

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlhäufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crinò L, Blumenschein GR Jr, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR. Borghaei H, et al. Among authors: barlesi f. N Engl J Med. 2015 Oct 22;373(17):1627-39. doi: 10.1056/NEJMoa1507643. Epub 2015 Sep 27. N Engl J Med. 2015. PMID: 26412456 Free PMC article. Clinical Trial.

2

Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?

Greillier L, Barlési F, Doddoli C, Durieux O, Torre JP, Gimenez C, Kleisbauer JP. Greillier L, et al. Among authors: barlesi f. Respiration. 2004 Mar-Apr;71(2):178-83. doi: 10.1159/000076681. Respiration. 2004. PMID: 15031575

3

Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer.

Barlési F, Gimenez C, Torre JP, Doddoli C, Mancini J, Greillier L, Roux F, Kleisbauer JP. Barlési F, et al. Respir Med. 2004 Apr;98(4):357-62. doi: 10.1016/j.rmed.2003.11.003. Respir Med. 2004. PMID: 15080079 Free article.

4

Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy.

Barlési F, Doddoli C, Torre JP, Giudicelli R, Fuentes P, Thomas P, Astoul P. Barlési F, et al. Eur J Cardiothorac Surg. 2005 Oct;28(4):629-34. doi: 10.1016/j.ejcts.2005.06.018. Eur J Cardiothorac Surg. 2005. PMID: 16125957

5

Second-line treatment for advanced non-small cell lung cancer: a systematic review.

Barlési F, Jacot W, Astoul P, Pujol JL. Barlési F, et al. Lung Cancer. 2006 Feb;51(2):159-72. doi: 10.1016/j.lungcan.2005.08.017. Epub 2005 Dec 19. Lung Cancer. 2006. PMID: 16360238 Review.

6

[Phase III randomised trial of adjuvant chemotherapy with cisplatin plus docetaxel versus cisplatin plus gemcitabine in resected non-small cell bronchial carcinoma with quality of life as the primary objective].

Barlési F, Barrau K, Doddoli C, Morange S, Thirion X, Astoul P, Auquier P, Thomas P. Barlési F, et al. Rev Mal Respir. 2006 Nov;23(5 Pt 1):489-96. doi: 10.1016/s0761-8425(06)71825-3. Rev Mal Respir. 2006. PMID: 17314754 Clinical Trial. French.

7

Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years.

Breen D, Barlési F, Zemerli M, Doddoli C, Torre JP, Thomas P, Astoul P. Breen D, et al. Among authors: barlesi f. Clin Lung Cancer. 2007 Mar;8(5):331-4. doi: 10.3816/CLC.2007.n.013. Clin Lung Cancer. 2007. PMID: 17562233

8

The place of excision repair cross complementation 1 (ERCC1) in surgically treated non-small cell lung cancer.

Breen D, Barlési F. Breen D, et al. Among authors: barlesi f. Eur J Cardiothorac Surg. 2008 May;33(5):805-11. doi: 10.1016/j.ejcts.2008.01.067. Epub 2008 Mar 14. Eur J Cardiothorac Surg. 2008. PMID: 18342529 Review.

9

Non-small cell lung cancer-smokers or non-smokers, does it matter?

Barlési F, Nanni-Metellus I, Breen D, Fina F, Astoul P, Martin PM. Barlési F, et al. Lung Cancer. 2009 Mar;63(3):430-2. doi: 10.1016/j.lungcan.2008.08.001. Epub 2008 Sep 11. Lung Cancer. 2009. PMID: 18789554

10

[Small-cell lung cancer].

Barlesi F. Barlesi F. Rev Prat. 2009 Sep 20;59(7):957-61. Rev Prat. 2009. PMID: 19839466 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

458 results

Search Page